Background: There is currently a lack of reports on prospective randomized controlled trials (RCTs) focused on personalized nutritional support in pancreatic surgery. This study aimed to evaluate the impact of perioperative individualized nutritional intervention on the outcomes of patients undergoing pancreatic surgery within the framework of enhanced recovery after surgery (ERAS).
Methods: This prospective cohort study enrolled 96 patients, randomly divided into a trial group and a control group in a 1:1 ratio. The primary endpoint was the change in body composition, including body cell mass (BCM), fat-free mass (FFM), skeletal muscle mass (SMM), and phase angle (PA). Secondary outcomes included time to first postoperative flatus, time to first bowel movement, length of hospital stay, and nutritional indicators.
Results: No significant differences were observed in the demographic characteristics between the two groups. The ratio of actual total calorie intake to recommended daily intake in the trial group was significantly higher than the control group (87.01% vs. 69.50%, P < 0.001). The ratio of actual protein intake to recommended daily intake was significantly higher in the trial group than the control group (96.18% vs.76.29%, P < 0.001). In body composition data, significant differences were found between the two groups in the ratio of BCM, FFM, and SMM at the study endpoint compared to admission. Additionally, a significant difference between the two groups was present in the ratio of BCM, FFM, and SMM at the third postoperative day (POD 3) compared with those at admission. While no significant differences were found between the groups in time to first flatus and time to first stool, the trial group had a significantly shorter postoperative hospital stay compared to the control group (15.9d vs. 20.4d, P = 0.046). Nutritional index analysis revealed a statistically significant difference in the ratio of serum total protein at the study endpoint compared POD 3 (P < 0.05), but no significant differences were found in serum prealbumin, albumin, and hemoglobin.
Conclusions: Personalized nutritional interventions throughout the perioperative period improved patients' nutritional status and reduced the length of postoperative hospital stay.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871664 | PMC |
http://dx.doi.org/10.1186/s41043-025-00758-w | DOI Listing |
Hepatology
March 2025
Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
Background And Aims: Portal vein tumor thrombosis (PVTT), an indicator of clinical metastasis, significantly shortens hepatocellular carcinoma (HCC) patients' lifespan, and no effective treatment has been established. We aimed to illustrate mechanisms underlying PVTT formation and tumor metastasis, and identified potential targets for clinical intervention.
Approach And Results: Multi-omics data of 159 HCC patients (including 37 cases with PVTT) was analyzed to identify contributors to PVTT formation and tumor metastasis.
Sci Adv
March 2025
Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, Sydney, New South Wales, Australia.
Pancreatic cancer (PC) is a highly metastatic malignancy. More than 80% of patients with PC present with advanced-stage disease, preventing potentially curative surgery. The neuropeptide Y (NPY) system, best known for its role in controlling energy homeostasis, has also been shown to promote tumorigenesis in a range of cancer types, but its role in PC has yet to be explored.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
March 2025
Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
Chronic infections with hepatitis E virus (HEV), especially those of genotype 3 (G3), frequently lead to liver fibrosis and cirrhosis in patients. However, the causation and mechanism of liver fibrosis triggered by chronic HEV infection remain poorly understood. Here, we found that the viral multiple-domain replicase (ORF1) undergoes unique ubiquitin-proteasomal processing leading to formation of the EV-erived MAD ctivator (HDSA), a viral polypeptide lacking putative helicase and RNA polymerase domains.
View Article and Find Full Text PDFPLoS One
March 2025
Cell Biology-Inspired Tissue Engineering (cBITE), MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
Type 1 diabetic (T1D) patients are life-long dependent on insulin therapy to keep their blood glucose levels under control. An alternative cell-based therapy for exogenous insulin injections is clinical islet transplantation (CIT). Currently the widespread application of CIT is limited, due to risks associated with the life-long use of immunosuppressive drugs to prevent rejection of donor cells.
View Article and Find Full Text PDFDiscov Oncol
March 2025
Department of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China.
Disulfidptosis, a novel form of disulfide stress-induced cell death involved in tumor progression, hasn't be well defined the function in tumor progression. And the clinical impacts of disulfidptosis-related genes (DRGs) in pancreatic adenocarcinoma (PAAD) remain largely unclear. In this study, we identified two distinct disulfidptosis subtypes and found that multilayer DRG alterations were associated with prognosis and TME infiltration characteristics.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!